Targeting tumor-initiating cells: Eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction-Reference-Cited by-同舟云学术

Targeting tumor-initiating cells: Eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction

Published:2015-02-10 Issue:7 Volume:6 Page:4585-4601
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lamb Rebecca¹²,Harrison Hannah¹²,Smith Duncan L.³,Townsend Paul A.¹,Jackson Thomas¹,Ozsvari Bela¹²,Martinez-Outschoorn Ubaldo E.⁴,Pestell Richard G.⁴,Howell Anthony¹²,Lisanti Michael P.¹²,Sotgia Federica¹²

Affiliation:

1. The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, University of Manchester, UK

2. The Breakthrough Breast Cancer Research Unit, Institute of Cancer Sciences, University of Manchester, UK

3. The Cancer Research UK Manchester Institute, University of Manchester, UK

4. The Kimmel Cancer Center, Philadelphia, PA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tryptamine, stem cell/progenitor protein biosynthesis, and aminoacyl-tRNA biosynthesis;Tryptamine Microbiota-Deregulated Aminoacyl-tRNA Biosynthesis;2024

2. Metabolic control of cancer metastasis: role of amino acids at secondary organ sites;Oncogene;2023-10-18

3. Glioblastoma initiation, migration, and cell types are regulated by core bHLH transcription factors ASCL1 and OLIG2;2023-10-02

4. A curcumin analogue GO‐Y030 depletes cancer stem cells by inhibiting the interaction between the HSP70/HSP40 complex and its substrates;FEBS Open Bio;2023-01-24

5. Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer;Cancer Cell International;2022-12-30